Literature DB >> 23288248

Progenitor-derived oligodendrocyte culture system from human fetal brain.

Maria Chiara G Monaco1, Dragan Maric, Alexandra Bandeian, Emily Leibovitch, Wan Yang, Eugene O Major.   

Abstract

Differentiation of human neural progenitors into neuronal and glial cell types offers a model to study and compare molecular regulation of neural cell lineage development. In vitro expansion of neural progenitors from fetal CNS tissue has been well characterized. Despite the identification and isolation of glial progenitors from adult human sub-cortical white matter and development of various culture conditions to direct differentiation of fetal neural progenitors into myelin producing oligodendrocytes, acquiring sufficient human oligodendrocytes for in vitro experimentation remains difficult. Differentiation of galactocerebroside(+) (GalC) and O4(+) oligodendrocyte precursor or progenitor cells (OPC) from neural precursor cells has been reported using second trimester fetal brain. However, these cells do not proliferate in the absence of support cells including astrocytes and neurons, and are lost quickly over time in culture. The need remains for a culture system to produce cells of the oligodendrocyte lineage suitable for in vitro experimentation. Culture of primary human oligodendrocytes could, for example, be a useful model to study the pathogenesis of neurotropic infectious agents like the human polyomavirus, JCV, that in vivo infects those cells. These cultured cells could also provide models of other demyelinating diseases of the central nervous system (CNS). Primary, human fetal brain-derived, multipotential neural progenitor cells proliferate in vitro while maintaining the capacity to differentiate into neurons (progenitor-derived neurons, PDN) and astrocytes (progenitor-derived astrocytes, PDA) This study shows that neural progenitors can be induced to differentiate through many of the stages of oligodendrocytic lineage development (progenitor-derived oligodendrocytes, PDO). We culture neural progenitor cells in DMEM-F12 serum-free media supplemented with basic fibroblast growth factor (bFGF), platelet derived growth factor (PDGF-AA), Sonic hedgehog (Shh), neurotrophic factor 3 (NT-3), N-2 and triiodothyronine (T3). The cultured cells are passaged at 2.5e6 cells per 75cm flasks approximately every seven days. Using these conditions, the majority of the cells in culture maintain a morphology characterized by few processes and express markers of pre-oligodendrocyte cells, such as A2B5 and O-4. When we remove the four growth factors (GF) (bFGF, PDGF-AA, Shh, NT-3) and add conditioned media from PDN, the cells start to acquire more processes and express markers specific of oligodendrocyte differentiation, such as GalC and myelin basic protein (MBP). We performed phenotypic characterization using multicolor flow cytometry to identify unique markers of oligodendrocyte.

Entities:  

Mesh:

Year:  2012        PMID: 23288248      PMCID: PMC3576417          DOI: 10.3791/4274

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

Review 1.  White matter progenitor cells reside in an oligodendrogenic niche.

Authors:  F J Sim; S A Goldman
Journal:  Ernst Schering Res Found Workshop       Date:  2005

2.  Single factors direct the differentiation of stem cells from the fetal and adult central nervous system.

Authors:  K K Johe; T G Hazel; T Muller; M M Dugich-Djordjevic; R D McKay
Journal:  Genes Dev       Date:  1996-12-15       Impact factor: 11.361

3.  Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism.

Authors:  G D'Intino; L Lorenzini; M Fernandez; A Taglioni; G Perretta; G Del Vecchio; P Villoslada; L Giardino; L Calzà
Journal:  J Neuroendocrinol       Date:  2011-09       Impact factor: 3.627

4.  bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells.

Authors:  A L Vescovi; B A Reynolds; D D Fraser; S Weiss
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

5.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.

Authors:  M C Raff; R H Miller; M Noble
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

6.  Neural progenitors from human embryonic stem cells.

Authors:  B E Reubinoff; P Itsykson; T Turetsky; M F Pera; E Reinhartz; A Itzik; T Ben-Hur
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

7.  An oligodendrocyte precursor cell line from rat optic nerve.

Authors:  G Almazan; R McKay
Journal:  Brain Res       Date:  1992-05-08       Impact factor: 3.252

8.  Oligodendroblasts distinguished from O-2A glial progenitors by surface phenotype (O4+GalC-) and response to cytokines using signal transducer LIFR beta.

Authors:  A L Gard; W C Williams; M R Burrell
Journal:  Dev Biol       Date:  1995-02       Impact factor: 3.582

9.  A niche-defying feat: induced oligoneogenesis in the adult dentate gyrus.

Authors:  Steven A Goldman; Sridaran Natesan
Journal:  Cell Stem Cell       Date:  2008-08-07       Impact factor: 24.633

10.  Efficient serum-free derivation of oligodendrocyte precursors from neural stem cell-enriched cultures.

Authors:  Rajesh C Rao; Justin Boyd; Raji Padmanabhan; Josh G Chenoweth; Ronald D McKay
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

View more
  14 in total

1.  Activated T cells induce proliferation of oligodendrocyte progenitor cells via release of vascular endothelial cell growth factor-A.

Authors:  Elliot H Choi; Yadi Xu; Marie Medynets; Maria Chiara G Monaco; Eugene O Major; Avindra Nath; Tongguang Wang
Journal:  Glia       Date:  2018-11       Impact factor: 7.452

2.  Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression.

Authors:  Michael W Ferenczy; Kory R Johnson; Shannon M Steinberg; Leslie J Marshall; Maria Chiara Monaco; Alexander M Beschloss; Peter N Jensen; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-20       Impact factor: 4.147

3.  Human glial chimeric mice reveal astrocytic dependence of JC virus infection.

Authors:  Yoichi Kondo; Martha S Windrem; Lisa Zou; Devin Chandler-Militello; Steven J Schanz; Romane M Auvergne; Sarah J Betstadt; Amy R Harrington; Mahlon Johnson; Alexander Kazarov; Leonid Gorelik; Steven A Goldman
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

4.  The "central vein sign" in inflammatory demyelination: The role of fibrillar collagen type I.

Authors:  Martina Absinta; Govind Nair; Maria Chiara G Monaco; Dragan Maric; Nathanael J Lee; Seung-Kwon Ha; Nicholas J Luciano; Pascal Sati; Steven Jacobson; Daniel S Reich
Journal:  Ann Neurol       Date:  2019-03-30       Impact factor: 10.422

Review 5.  Models for Studying Myelination, Demyelination and Remyelination.

Authors:  I Osorio-Querejeta; M Sáenz-Cuesta; M Muñoz-Culla; D Otaegui
Journal:  Neuromolecular Med       Date:  2017-05-23       Impact factor: 3.843

Review 6.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

7.  Differentiation of human fetal multipotential neural progenitor cells to astrocytes reveals susceptibility factors for JC virus.

Authors:  Michael W Ferenczy; Kory R Johnson; Leslie J Marshall; Maria Chiara Monaco; Eugene O Major
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

8.  Study on the Safety of Human Oligodendrocyte Precursor Cell Transplantation in Young Animals and Its Efficacy on Myelination.

Authors:  Haipeng Zhou; Siliang Lu; Ke Li; Yinxiang Yang; Caiyan Hu; Zhaoyan Wang; Qian Wang; Ying He; Xiaohua Wang; Dou Ye; Qian Guan; Jing Zang; Chang Liu; Suqing Qu; Zuo Luan
Journal:  Stem Cells Dev       Date:  2021-04-29       Impact factor: 3.272

9.  Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis.

Authors:  Brienne A McKenzie; Manmeet K Mamik; Leina B Saito; Roobina Boghozian; Maria Chiara Monaco; Eugene O Major; Jian-Qiang Lu; William G Branton; Christopher Power
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-12       Impact factor: 11.205

Review 10.  Human polyomavirus reactivation: disease pathogenesis and treatment approaches.

Authors:  Cillian F De Gascun; Michael J Carr
Journal:  Clin Dev Immunol       Date:  2013-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.